缺血性卒中取栓前静脉溶栓的安全性与结局
基于SITS-ISTR国际登记数据库2014至2019年42个中心的6,350例前循环大动脉闭塞性卒中患者,其中3,944例(62.1%)接受静脉溶栓联合血管内取栓。倾向评分匹配分析显示,联合治疗组3个月功能独立率高于单纯取栓组(46.4% vs 40.3%,p<0.001),3个月死亡率更低(20.3% vs 23.3%,p=0.035),症状性颅内出血率相近(3.5% vs 3.0%,p=0.42)。
要点
- 取栓前静脉溶栓与更高的3个月功能独立率相关(46.4% vs 40.3%)。
- 联合治疗组3个月死亡率更低(20.3% vs 23.3%),症状性颅内出血率无显著差异。
- 证据等级为Class II,受观察性设计及混杂因素限制。
核心结论
- 在前循环大动脉闭塞性卒中患者中,取栓前接受静脉溶栓与更好的功能结局相关。
- 该研究提供Class II证据:取栓前静脉溶栓较单纯取栓提高3个月功能独立的概率。
研究设计与样本
- 研究为基于SITS-ISTR登记数据库的观察性研究,纳入2014至2019年42个中心共6,350例患者。
- 纳入中心需连续记录≥10例患者,且3个月改良Rankin量表(mRS)评分可获得率至少70%。
- 大动脉闭塞定义为颅内颈内动脉、大脑中动脉第一及第二段、大脑前动脉第一段闭塞。
- 分析方法为倾向评分匹配(PSM)及多因素logistic回归分析。
主要发现
- 3,944例(62.1%)接受静脉溶栓联合取栓,联合治疗组心房颤动、持续抗凝、既往卒中、心力衰竭及卒中前残疾比例较低。
- PSM分析显示联合治疗组功能独立(mRS 0-2)率高于单纯取栓组(46.4% vs 40.3%,p<0.001)。
- 联合治疗组3个月死亡率低于单纯取栓组(20.3% vs 23.3%,p=0.035)。
- 症状性颅内出血率两组相近(3.5% vs 3.0%,p=0.42)。
- 多因素校正结果与PSM分析一致。
关键数值与推荐
- 主要结局为3个月功能独立(mRS评分0-2)、3个月死亡及按修改版SITS-Monitoring Study定义的症状性颅内出血(SICH)。
- 功能独立率:IVT+EVT组46.4% vs 单纯EVT组40.3%,p<0.001。
- 3个月死亡率:IVT+EVT组20.3% vs 单纯EVT组23.3%,p=0.035。
- SICH率:IVT+EVT组3.5% vs 单纯EVT组3.0%,p=0.42。
临床怎么用
- 结果提示在国际常规临床实践中,前循环大动脉闭塞性卒中取栓前接受静脉溶栓可能与更优功能结局相关。
- 解读时应结合观察性设计带来的混杂可能,不能据此直接推断因果关系。
局限性
- 研究为观察性设计,存在未测量的混杂因素。
- 可能存在适应症相关的残余混杂。
- 结论反映国际常规临床实践,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the hypothesis that IV thrombolysis (IVT) treatment before endovascular thrombectomy (EVT) is associated with better outcomes in patients with anterior circulation large artery occlusion (LAO) stroke, we examined a large real-world database, the Safe Implementation of Treatment in Stroke-International Stroke Thrombectomy Register (SITS-ISTR). METHODS: We identified centers recording ≥10 consecutive patients in the SITS-ISTR, with at least 70% available modified Rankin Scale (mRS) scores at 3 months during 2014 to 2019. We defined LAO as intracranial internal carotid artery, first and second segment of middle cerebral artery, and first segment of anterior cerebral artery. Main outcomes were functional independence (mRS score 0-2) and death at 3 months and symptomatic intracranial hemorrhage (SICH) per modified SITS-Monitoring Study. We performed propensity score-matched (PSM) and multivariable logistic regression analyses. RESULTS: Of 6,350 patients from 42 centers, 3,944 (62.1%) received IVT. IVT + EVT-treated patients had less frequent atrial fibrillation, ongoing anticoagulation, previous stroke, heart failure, and prestroke disability. PSM analysis showed that IVT + EVT-treated patients had a higher rate of functional independence than patients treated with EVT alone (46.4% vs 40.3%, p < 0.001) and a lower rate of death at 3 months (20.3% vs 23.3%, p = 0.035). SICH rates (3.5% vs 3.0%, p = 0.42) were similar in both groups. Multivariate adjustment yielded results consistent with PSM. CONCLUSION: Pretreatment with IVT was associated with favorable outcomes in EVT-treated LAO stroke in the SITS-ISTR. These findings, while indicative of international routine clinical practice, are limited by observational design, unmeasured confounding, and possible residual confounding by indication. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that IVT before EVT increases the probability of functional independence at 3 months compared to EVT alone.
引用
- Ahmed N, Mazya M, Nunes AP, et al. Safety and Outcomes of Thrombectomy in Ischemic Stroke With vs Without IV Thrombolysis. Neurology. 2021. PMID: 34088873. doi:10.1212/WNL.0000000000012327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。